Catch up on the top radiology content of the past week.
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Meta-Analysis Shows Merits of (68Ga)Ga-FAPI-04 PET for Assessing GI Tumors and Metastases
For patients with gastric cancer, (68Ga)Ga-FAPI-04 PET offered double the sensitivity for lymph node metastases in comparison to (18F)FDG PET.
-
FDA Clears CT-Based AI Software for Subdural Collections
The AI-powered Viz Subdural Plus reportedly provides automated measurements and labeling of subdural collections, including subdural hemorrhages (SDHs), based on non-contrast CT scans.
-
Adjunctive AI Leads to 40 Percent Increase in CT Sensitivity for Lung Metastases in Patients with Colorectal Cancer
Researchers also noted a greater than 30 percent increase in treatment management changes resulting from the use of CT-based adjunctive AI to detect lung metastases in colorectal cancer patients.
-
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
-
How to Successfully Launch a CCTA Program at Your Hospital or Practice
Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
-
New PSMA PET Prep Product Now Available in the U.S.
Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
-
Study: CT Colonography Screening Offers Up to 16 Percent Higher Reduction of Colorectal Cancer Incidence than Cologuard
Emerging research suggests the use of computed tomography colonography (CTC) in colorectal cancer screening may provide significantly higher preventive benefit at lower costs in comparison to multitarget stool DNA testing.
-
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
In a recent interview, Sherry Shen, M.D., discussed the potential impact of FES PET recently being recommended by the National Comprehensive Cancer Network (NCCN) Guidelines for the staging of recurrent or metastatic estrogen receptor-positive (ER+) lobular breast cancer.
-
Olympus Launches CT-Based AI Software for Emphysema Screening
Through AI assessment of chest CT scans, the SeleCT Screening may help identify candidates for bronchoscopic lung volume reduction to improve lung function.